to-BBB is a Dutch biotechnology company that brings drugs to the brain that normally cannot enter the brain. to-BBB offers a patented central CNS drug targeting technology to partners in pharmaceutical and biotechnology industries. to-BBB was spun out of the Blood-Brain Barrier Research Group of the Leiden/Amsterdam Center for Drug Research from Leiden University in The Netherlands.